<SEC-DOCUMENT>0001157523-14-002485.txt : 20140624
<SEC-HEADER>0001157523-14-002485.hdr.sgml : 20140624
<ACCEPTANCE-DATETIME>20140606160547
ACCESSION NUMBER:		0001157523-14-002485
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20140605
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
FILED AS OF DATE:		20140606
DATE AS OF CHANGE:		20140606

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anika Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000898437
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043145961
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14027
		FILM NUMBER:		14896639

	BUSINESS ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730
		BUSINESS PHONE:		(781) 457-9000

	MAIL ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA THERAPEUTICS INC
		DATE OF NAME CHANGE:	19970114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA RESEARCH INC
		DATE OF NAME CHANGE:	19930309
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a50881542.htm
<DESCRIPTION>ANIKA THERAPEUTICS, INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2014 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <p>

    </p>
    <hr style="text-align: center; width: 100%; color: #000000; height: 1.0 pt">


    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 17pt"><b>UNITED
      STATES</b></font><b><font style="font-family: Times New Roman; font-size: 17pt"><br style="font-size: 17pt; font-family: Times New Roman"></font><font style="font-family: Times New Roman; font-size: 17pt">SECURITIES
      AND EXCHANGE COMMISSION</font></b><font style="font-size: 10pt"><br style="font-size: 10pt"></font><font style="font-size: 12pt"><b>WASHINGTON,
      D.C. 20549</b></font><br><br><br><font style="font-family: Times New Roman; font-size: 17pt"><b>FORM
      8-K</b></font><br><br><br><font style="font-family: Times New Roman; font-size: 10pt">CURRENT
      REPORT</font><font style="font-family: Times New Roman; font-size: 10pt"><br style="font-size: 10pt; font-family: Times New Roman"></font><font style="font-family: Times New Roman; font-size: 10pt">Pursuant
      to Section 13 or 15(d) of the Securities Exchange Act of 1934</font><br><font style="font-family: Times New Roman; font-size: 10pt"><br style="font-size: 10pt; font-family: Times New Roman"></font><font style="font-family: Times New Roman; font-size: 10pt">Date
      of Report (Date of earliest event reported): June 5, 2014</font><font style="font-family: Times New Roman; font-size: 10pt"><br style="font-size: 10pt; font-family: Times New Roman"></font><br><br>
    </p>
    <div style="text-align:center">
    <table style="font-size: 10pt; font-family: Times New Roman; width: 100%; margin-bottom: 10.0px; margin-left:auto;margin-right:auto" cellspacing="0">
      <tr>
        <td valign="top" style="text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <font style="font-family: Times New Roman; font-size: 20pt"><b>Anika
            Therapeutics, Inc.</b></font>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (Exact name of registrant as specified in its charter)
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="text-align:center">
    <table style="font-size: 10pt; font-family: Times New Roman; width: 100%; margin-bottom: 10.0px; margin-left:auto;margin-right:auto" cellspacing="0">
      <tr>
        <td valign="bottom" style="width: 33%; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Massachusetts</b>
          </p>
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 34%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>000-21326</b>
          </p>
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 33%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>04-3145961</b>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="width: 33%; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (State or other jurisdiction<br>of incorporation)
          </p>
        </td>
        <td valign="top" style="width: 34%; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (Commission File<br>Number)
          </p>
        </td>
        <td valign="top" style="width: 33%; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (IRS Employer<br>Identification No.)
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="text-align:center">
    <table style="font-size: 10pt; font-family: Times New Roman; width: 100%; margin-bottom: 10.0px; margin-left:auto;margin-right:auto" cellspacing="0">
      <tr>
        <td valign="top" style="width: 40%; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>32 Wiggins Avenue<br>Bedford, Massachusetts</b>
          </p>
        </td>
        <td valign="bottom" style="width: 20%; text-align: center; padding-left: 0.0px">
          &#160;
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 40%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>01730</b>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="width: 40%; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (Address of principal executive offices)
          </p>
        </td>
        <td style="width: 20%">

        </td>
        <td valign="top" style="width: 40%; text-align: center; padding-left: 0.0px">
          (Zip Code)
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <p style="white-space: nowrap; text-align: center">
      Registrant&#8217;s telephone number, including area code:<b>&#160;&#160;(781)
      457-9000</b><br><br><b>N/A</b><br>&#160;(Former name or former address, if
      changed since last report.)<br>
    </p>
    <p style="text-align: center">

    </p>
    <p>
      <font style="font-size: 10pt; font-family: Times New Roman">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions:</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font>
    </p>
    <div style="text-indent: 0pt; width: 100%; margin-bottom: 10pt; margin-left: 0pt; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="font-size: 10pt; text-indent: 30.0px">
      <b>Item 5.07 Submission of Matters to a Vote of Security Holders.</b>
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px; text-align: justify">
      The Company held its Annual Meeting of Stockholders on June 5, 2014.
      Proxies were solicited pursuant to the Company&#8217;s proxy statement filed
      on April 23, 2014, with the Securities and Exchange Commission under
      Section 14(a) of the Securities Exchange Act of 1934. There was no
      solicitation in opposition to the Company&#8217;s solicitation. At the
      meeting, holders of the Company&#8217;s common stock were asked:
    </p>
    <p style="text-indent: 60.0px">

    </p>
    <p style="font-size: 10pt; text-indent: 30.0px; text-align: justify">
      1.&#160;&#160;To elect two (2) Class III directors nominated by the Board of
      Directors, each to serve until the 2017 Annual Meeting of Stockholders
      and until their respective successors are duly elected and qualified;
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px; text-align: justify">
      2.&#160;&#160;To ratify the appointment of PricewaterhouseCoopers LLP as the
      Company&#8217;s independent registered public accounting firm for the 2014
      fiscal year; and
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px; text-align: justify">
      3.&#160;&#160;To consider and approve an advisory vote regarding the compensation
      of the Company&#8217;s Named Executive Officers.
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px; text-align: justify">
      A total of 13,102,301 shares of Common Stock were present in person or
      by proxy at the meeting, representing approximately 89.69% of the voting
      power of the Company entitled to vote at the meeting. Each share of the
      Company&#8217;s common stock was entitled to one vote with respect to matters
      submitted to a vote of the Company&#8217;s stockholders, and the voting
      results reported below are final.
    </p>
    <p style="text-indent: 60.0px">

    </p>
    <p>
      <u><b>PROPOSAL 1</b></u>
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px">
      Each of the Company&#8217;s nominees for director as listed in the proxy
      statement was re-elected as shown in the table below: &#160;
    </p>
    <p style="text-indent: 60.0px">

    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; font-family: Times New Roman; width: 100%; margin-bottom: 10.0px" cellspacing="0">
      <tr>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; width: 25%; text-align: left; padding-left: 0.0px">
          <b>Nominee</b>
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; width: 25%; text-align: center; padding-left: 0.0px">
          <b>Votes &#8220;For&#8221;</b>
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; width: 25%; text-align: center; padding-left: 0.0px">
          <b>Votes Withheld</b>
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; width: 25%; text-align: center; padding-left: 0.0px">
          <b>Broker</b>

          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Non-Votes</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 25%">

        </td>
        <td style="width: 25%">

        </td>
        <td style="width: 25%">

        </td>
        <td style="width: 25%">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="width: 25%; text-align: left; padding-left: 0.0px">
          Dr. Charles H. Sherwood
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          9,899,530
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          232,076
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          2,970,695
        </td>
      </tr>
      <tr>
        <td style="width: 25%">

        </td>
        <td style="width: 25%">

        </td>
        <td style="width: 25%">

        </td>
        <td style="width: 25%">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="width: 25%; text-align: left; padding-left: 0.0px">
          Mr. Steven E. Wheeler
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          9,780,050
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          351,556
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          2,970,695
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <p>
      <u><b>PROPOSAL 2</b></u>
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px; text-align: justify">
      Stockholders also ratified the appointment of PricewaterhouseCoopers LLP
      as the Company&#8217;s independent registered public accounting firm for the
      2014 fiscal year as shown in the table below:&#160;
    </p>
    <p style="text-indent: 60.0px">

    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; font-family: Times New Roman; width: 100%; margin-bottom: 10.0px" cellspacing="0">
      <tr>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; width: 25%; text-align: center; padding-left: 0.0px">
          <b>For</b>
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; width: 25%; text-align: center; padding-left: 0.0px">
          <b>Against</b>
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; width: 25%; text-align: center; padding-left: 0.0px">
          <b>Abstained</b>
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; width: 25%; text-align: center; padding-left: 0.0px">
          <b>Broker</b>

          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Non-Votes</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 25%">

        </td>
        <td style="width: 25%">

        </td>
        <td style="width: 25%">

        </td>
        <td style="width: 25%">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          13,007,918
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          54,468
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          39,915
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          0
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <p>
      <u><b>PROPOSAL 3</b></u>
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px; text-align: justify">
      Stockholders approved, on an advisory basis, the compensation paid to
      the Company&#8217;s Named Executive Officers, as disclosed pursuant to Item
      402 of Regulation S-K, including the Compensation Discussion and
      Analysis, compensation tables and narrative discussion set forth in the
      Proxy Statement of the Meeting as shown in the table below:
    </p>
    <p style="text-indent: 60.0px">

    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; font-family: Times New Roman; width: 100%; margin-bottom: 10.0px" cellspacing="0">
      <tr>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; width: 25%; text-align: center; padding-left: 0.0px">
          <b>For</b>
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; width: 25%; text-align: center; padding-left: 0.0px">
          <b>Against</b>
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; width: 25%; text-align: center; padding-left: 0.0px">
          <b>Abstained</b>
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; width: 25%; text-align: center; padding-left: 0.0px">
          <b>Broker</b>

          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Non-Votes</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 25%">

        </td>
        <td style="width: 25%">

        </td>
        <td style="width: 25%">

        </td>
        <td style="width: 25%">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            9,480,290
          </p>
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          556,883
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          94,433
        </td>
        <td valign="bottom" style="padding-right: 0.0px; width: 25%; white-space: nowrap; text-align: center; padding-left: 0.0px">
          2,970,695
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="text-indent: 0pt; width: 100%; margin-bottom: 10pt; margin-left: 0pt; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      <br>
      <br>
      <br>

    </p>
    <p style="text-align: center">
      <u><font style="font-size: 10pt; font-family: Times New Roman">SIGNATURES</font></u><br>
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px">
      Pursuant to the requirements of the Securities Exchange Act of 1934, the
      registrant has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.
    </p>
    <p>

    </p>
    <div style="text-align:center">
    <table style="font-size: 10pt; font-family: Times New Roman; width: 100%; margin-bottom: 10.0px; margin-left:auto;margin-right:auto" cellspacing="0">
      <tr>
        <td style="width: 50%">

        </td>
        <td colspan="3" valign="top" style="text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Anika Therapeutics, Inc.
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 50%">

        </td>
        <td colspan="2" valign="top" style="text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td style="width: 12%">

        </td>
      </tr>
      <tr>
        <td valign="top" style="width: 50%; padding-bottom: 2.0px; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Date: June 6, 2014
          </p>
        </td>
        <td valign="top" style="width: 8%; padding-bottom: 2.0px; text-align: left; padding-left: 0.0px">
          By:
        </td>
        <td valign="top" style="border-bottom: solid black 1.0pt; width: 30%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            /s/ Sylvia Cheung
          </p>
        </td>
        <td style="width: 12%">

        </td>
      </tr>
      <tr>
        <td style="width: 50%">

        </td>
        <td valign="top" style="width: 8%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Name:
          </p>
        </td>
        <td colspan="2" valign="top" style="text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Sylvia Cheung
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 50%">

        </td>
        <td valign="top" style="width: 8%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Title:
          </p>
        </td>
        <td colspan="2" valign="top" style="text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Chief Financial Officer
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
